EBIT at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's EBIT?
- Alto Neuroscience (ANRO) reported EBIT of -$27.14M in Q1 2026.
- How has Alto Neuroscience's EBIT changed year-over-year?
- Alto Neuroscience's EBIT decreased by 73.1% year-over-year, from -$15.68M to -$27.14M.
- What is the long-term trend for Alto Neuroscience's EBIT?
- Over 2 years (2023 to 2025), Alto Neuroscience's EBIT has grown at a 32.5% compound annual growth rate (CAGR), from -$37.81M to -$66.36M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.